552
Participants
Start Date
September 17, 2019
Primary Completion Date
October 31, 2025
Study Completion Date
October 31, 2025
Acalabrutinib
Acalabrutinib will be administered as one 100 mg capsule taken orally, twice daily with 8 ounces (approximately 240 mL) of water.
Research Site, Tainan City
Research Site, Oslo
Research Site, København Ø
Research Site, Herlev
Research Site, Fitzroy
Research Site, Clayton
Research Site, Roskilde
Research Site, South Brisbane
Research Site, Adelaide
Research Site, Odense
Research Site, Bedford Park
Research Site, Bergen
Research Site, Nedlands
Research Site, Trondheim
Research Site, Aarhus
Research Site, Aalborg
Research Site, Taipei
Research Site, Taipei
Research Site, Bethlehem
Research Site, Milan
Research Site, Madrid
Research Site, Madrid
Research Site, Marbella
Research Site, Brest
Research Site, Marietta
Research Site, Ourense
Research Site, Jacksonville
Research Site, Porta Westfalica
Research Site, Oviedo
Research Site, Bordeaux
Research Site, Tampere
Research Site, St. Petersburg
Research Site, Fort Myers
Research Site, Tours
Research Site, Nashville
Research Site, Chattanooga
Research Site, Taichung
Research Site, Ulsan
Research Site, Essen
Research Site, Indianapolis
Research Site, Fort Wayne
Research Site, Busan
Research Site, Zaragoza
Research Site, Reims
Research Site, Siena
Research Site, Vandœuvre-lès-Nancy
Research Site, Saint Cloud
Research Site, Peoria
Research Site, Normal
Research Site, Bayern
Research Site, Kansas City
Research Site, Homburg
Research Site, Kuopio
Research Site, Shreveport
Research Site, Schwäbisch Hall
Research Site, Uppsala
Research Site, Dallas
Research Site, Chandler
Research Site, Limoges
Research Site, Catanzaro
Research Site, Whittier
Research Site, Long Beach
Research Site, Redlands
Research Site, Luleå
Research Site, Moscow
Research Site, Moscow
Research Site, Moscow
Research Site, Syktyvkar
Research Site, Petrozavodsk
Research Site, Saint Petersburg
Research Site, Saint Petersburg
Research Site, Saint Petersburg
Research Site, Saint Petersburg
Research Site, Saint Petersburg
Research Site, Smolensk
Research Site, Smolensk
Research Site, Nizhny Novgorod
Research Site, Belo Horizonte
Research Site, Curitiba
Research Site, Goiânia
Research Site, Porto Alegre
Research Site, Porto Alegre
Research Site, Ribeirão Preto
Research Site, São Paulo
Research Site, São Paulo
Research Site, Calgary
Research Site, Edmonton
Research Site, Victoria
Research Site, Winnipeg
Research Site, Halifax
Research Site, Brampton
Research Site, Newmarket
Research Site, Ottawa
Research Site, Hus
Research Site, Roma
Research Site, Roma
Research Site, Arnhem
Research Site, Dordrecht
Research Site, Utrecht
Research Site, Seoul
Research Site, Seoul
Research Site, Seoul
Research Site, Seoul
Research Site, Barcelona
Research Site, Vitoria-Gasteiz
Research Site, Lund
Research Site, Liverpool
Research Site, Newmarket
Lead Sponsor
Collaborators (1)
Parexel
INDUSTRY
AstraZeneca
INDUSTRY